Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03269630 · ClinicalTrials.gov registry record
New Orleans Pulmonary Hypertension Biobank
A clinical trial of Healthy and Pulmonary Hypertension, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- Recruiting
- Registry status
- 450
- Enrollment target
- 1
- Study location
NCT03269630: Recruiting study of Healthy and Pulmonary Hypertension, sponsored by Louisiana State University Health Sciences Center in New Orleans.
NCT03269630 is a study of Healthy and Pulmonary Hypertension that is actively recruiting participants, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 450 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03269630, a study of Healthy and Pulmonary Hypertension, is actively recruiting participants, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of biomarkers that can guide clinical care. The investigators are establishing a biobank to collect samples (blood, urine, stool) from patients with pulmonary hypertension, patients at high risk for pulmonary hypertension, healthy controls, and patients undergoing right heart catheterization. Specimens will be stored for future investigations.
Primary Outcome
Biospecimen collection only
Conditions Studied
Interventions
- OTHER No intervention. Biospecimen collection only
Study Locations (1)
Louisiana
- University Medical Center-New Orleans - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2017-12-29 |
| Est. Completion | 2027-10 |
What NCT03269630 shows while recruiting
NCT03269630 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (30% lower).
The record links to 5 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which No intervention. Biospecimen collection only is the first listed.
NCT03269630 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT03269630 about?
NCT03269630 is a clinical study titled "New Orleans Pulmonary Hypertension Biobank". Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of bi...
What is the current status of trial NCT03269630?
This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2017-12-29. Estimated completion is 2027-10.
What conditions does trial NCT03269630 study?
This clinical trial studies the following conditions: Healthy, Pulmonary Hypertension, Systemic Sclerosis, Heart Failure With Normal Ejection Fraction, Mixed Connective Tissue Disease.
What interventions are being tested in trial NCT03269630?
The interventions under investigation include: No intervention. Biospecimen collection only (OTHER).
Who is sponsoring clinical trial NCT03269630?
This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03269630 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03269630's enrollment target sits among peer trials
450 55th of 1090 higher than 1,036 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT04165070 · 450 participants · Phase 1
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI